Press Releases
October 4, 2017
SBP Achieves Significant Milestone with Successful Completion of Patient Enrollment in Phase 1a Dose Escalation Safety Study
August 10, 2017
SBP Files Form 10-Q for Second Quarter 2017 and Provides Clinical Update
June 7, 2017
SBP Announces Completion of 5th Patient Cohort in the Dose Escalation Phase 1a Study of SBP-101 for Pancreatic Cancer
June 7, 2017
SBP to Present at the 2017 Marcum MicroCap Conference on June 15
March 30, 2017
SBP Provides Phase 1 Trial Update; Patients Experience Early Signs of Efficacy
February 1, 2017
The NIH Awards SBP Grant to Study SBP-101 for the Treatment of Pancreatitis
December 7, 2016
SBP to Initiate 5th Patient Cohort in its Dose Escalation Phase 1 Study of SBP-101 for Pancreatic Cancer
November 10, 2016
SBP Reports Q316 Results, Provides Clinical Progress Update
October 24, 2016